Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06087198 · ClinicalTrials.gov registry record
Clinical Performance Evaluation of T-TAS®01 HD Chip
A clinical trial, sponsored by Hikari Dx.
- Completed
- Registry status
- 43
- Enrollment target
NCT06087198 is a clinical trial that has completed, run by Hikari Dx. The registered enrollment target is 43 participants.
The verdict
NCT06087198 has completed, sponsored by Hikari Dx.
- COMPLETED
- Registry status
- 43 participants
- Enrollment target
Study Summary
The study is being conducted to validate the clinical performance of the T-TAS 01 HD assay for measurement of thrombogenicity in patients with thrombocytopenia receiving a platelet transfusion.
Interventions
- DIAGNOSTIC_TEST T-TAS 01 HD Assay
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2023-09-25 |
| Est. Completion | 2025-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06087198
The ClinicalTrials.gov registry entry for NCT06087198 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hikari Dx, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which T-TAS 01 HD Assay is the first listed.
NCT06087198 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06087198 about?
NCT06087198 is a clinical study titled "Clinical Performance Evaluation of T-TAS®01 HD Chip". The study is being conducted to validate the clinical performance of the T-TAS 01 HD assay for measurement of thrombogenicity in patients with thrombocytopenia receiving a platelet transfusion.
What is the current status of trial NCT06087198?
This trial is currently completed. The enrollment target is 43 participants. The study started on 2023-09-25. Estimated completion is 2025-06-30.
What interventions are being tested in trial NCT06087198?
The interventions under investigation include: T-TAS 01 HD Assay (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06087198?
This trial is sponsored by Hikari Dx, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.